246240-10-8 Usage
Description
Tert-butyl (2-(3-aminophenoxy)ethyl)carbamate is a carbamate derivative with the molecular formula C14H23N2O3. It is composed of a tert-butyl group, an ethyl chain, and an aminophenoxy group connected by a carbamate linkage. This chemical compound is often utilized as a pharmaceutical intermediate in the synthesis of various drugs and is recognized for its potential therapeutic properties. However, its chemical structure and properties may also pose potential health and environmental risks, necessitating further research to fully understand its safety and potential applications.
Uses
Used in Pharmaceutical Industry:
Tert-butyl (2-(3-aminophenoxy)ethyl)carbamate is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique chemical structure allows it to serve as a building block in the development of new therapeutic agents.
Used in Research and Development:
In the field of research and development, tert-butyl (2-(3-aminophenoxy)ethyl)carbamate is employed as a test compound to study its potential therapeutic properties and to explore its interactions with biological systems. This helps in understanding its safety profile and identifying possible applications in medicine.
Used in Environmental and Health Risk Assessment:
Due to the potential health and environmental risks associated with tert-butyl (2-(3-aminophenoxy)ethyl)carbamate, it is used in studies aimed at assessing its impact on ecosystems and human health. This helps in developing guidelines and regulations for its safe handling and disposal.
Check Digit Verification of cas no
The CAS Registry Mumber 246240-10-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,4,6,2,4 and 0 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 246240-10:
(8*2)+(7*4)+(6*6)+(5*2)+(4*4)+(3*0)+(2*1)+(1*0)=108
108 % 10 = 8
So 246240-10-8 is a valid CAS Registry Number.
246240-10-8Relevant articles and documents
TYK2 PSEUDOKINASE LIGANDS
-
, (2020/10/20)
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
COMPOUNDS FOR TREATING OPHTHALMIC DISEASES AND DISORDERS
-
Page/Page column 155, (2010/05/13)
Provided are compounds, pharmaceutical compositions thereof, and methods of treating ophthalmic diseases and disorders, such as age-related macular degeneration and Stargardt's Disease, using said compounds and compositions.
Trisubstituted pyrimidines
-
, (2008/06/13)
The present invention relates to trisubstituted pyrimidines of formula wherein Ra to Re are defined as in claim 1, which are suitable for the treatment of illnesses in which β-amyloid modulators have a therapeutic benefit, the use th
